These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6624709)

  • 1. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and analytical performance of automated tests for antithrombin III and plasminogen on the Du Pont aca analyzer.
    Perry JF; Siefring GE; Reider MC; Coleman PL; Wehrly JA
    Clin Chem; 1983 Apr; 29(4):609-13. PubMed ID: 6831687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
    Sie P
    Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Clin Chem; 1983 Feb; 29(2):225-36. PubMed ID: 6821923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation testing with the Du Pont aca discrete clinical analyzer.
    Pierson-Perry JF; Wehrly JA; Siefring GE
    Semin Thromb Hemost; 1983 Oct; 9(4):321-33. PubMed ID: 6658463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous type I plasminogen deficiency.
    Mingers AM; Heimburger N; Zeitler P; Kreth HW; Schuster V
    Semin Thromb Hemost; 1997; 23(3):259-69. PubMed ID: 9255907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated antithrombin-III assays by synthetic substrate on the Multistat III.
    Bick RL; Wheeler A
    Am J Clin Pathol; 1987 Aug; 88(2):192-7. PubMed ID: 3618551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
    Fareed J; Messmore HL; Walenga JM; Bermes EW; Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):288-301. PubMed ID: 6817417
    [No Abstract]   [Full Text] [Related]  

  • 12. Automated instrumentation and the laboratory diagnosis of bleeding and thrombotic disorders.
    Walenga J; Fareed J; Bermes EW
    Semin Thromb Hemost; 1983 Jul; 9(3):172-93. PubMed ID: 6351253
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of antithrombin III laboratory tests.
    King PG; Huang AH; Palkuti HA; Farris VL
    Am J Clin Pathol; 1980 Apr; 73(4):537-40. PubMed ID: 7369177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoassay by particle counting for coagulation testing: application to the determination of antithrombin III, von Willebrand factor antigen (vWF:Ag) and plasminogen.
    Borque L; Cambiaso C; Lavenne E; Leautaud P; Mareschal JC; Collet-Cassart D
    J Clin Chem Clin Biochem; 1989 Mar; 27(3):175-9. PubMed ID: 2785154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorometric assay of antithrombin III. Diagnostic value in 112 patients with abnormal hemostasis.
    Napoli VM; Krzyzaniak R; Vroon DH; Newton JL
    Am J Clin Pathol; 1985 Aug; 84(2):173-9. PubMed ID: 4025221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C, antithrombin III and plasminogen: effect of age, sex and blood group.
    Dolan G; Neal K; Cooper P; Brown P; Preston FE
    Br J Haematol; 1994 Apr; 86(4):798-803. PubMed ID: 7918075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.